{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:27:39Z","timestamp":1790832459674,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"am","delay-in-days":264,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbrc.2024.150433","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T06:04:32Z","timestamp":1721455472000},"page":"150433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Enhanced CFTR modulator efficacy in \u0394F508 CFTR mouse organoids by ablation of RFFL ubiquitin ligase"],"prefix":"10.1016","volume":"733","author":[{"given":"Daichi","family":"Hinata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-0987","authenticated-orcid":false,"given":"Hiroshi","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6746-9112","authenticated-orcid":false,"given":"Yuka","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5175-2224","authenticated-orcid":false,"given":"Tsukasa","family":"Okiyoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.150433_bib1","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2024.150433_bib2","first-page":"S5","article-title":"Increasing life expectancy in cystic fibrosis: advances and challenges","volume":"57","author":"McBennett","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.bbrc.2024.150433_bib3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.biochem.75.103004.142532","article-title":"CFTR function and prospects for therapy","volume":"77","author":"Riordan","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbrc.2024.150433_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004499","article-title":"Emergent properties of proteostasis in managing cystic fibrosis","volume":"3","author":"Balch","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.bbrc.2024.150433_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fphar.2012.00201","article-title":"Mechanisms of CFTR folding at the endoplasmic reticulum","volume":"3","author":"Kim","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150433_bib6","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2024.150433_bib7","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa1709847","article-title":"Tezacaftor-ivacaftor in residual-function heterozygotes with cystic fibrosis","volume":"377","author":"Rowe","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2024.150433_bib8","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","article-title":"CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis","volume":"402","author":"Taylor-Cousar","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2024.150433_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105262","article-title":"Partial rescue of F508del-CFTR stability and trafficking defects by double corrector treatment","volume":"22","author":"Capurro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150433_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008889","article-title":"Some gating potentiators, including VX-770, diminish \u0394F508-CFTR functional expression","volume":"6","author":"Veit","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2024.150433_bib11","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.devcel.2018.02.001","article-title":"Chaperone-independent peripheral quality control of CFTR by RFFL E3 ligase","volume":"44","author":"Okiyoneda","year":"2018","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbrc.2024.150433_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.840649","article-title":"The ubiquitin ligase RNF34 participates in the peripheral quality control of CFTR (RNF34 role in CFTR PeriQC)","volume":"9","author":"Taniguchi","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbrc.2024.150433_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115730","article-title":"Identification of \u03b1-Tocopherol succinate as an RFFL-substrate interaction inhibitor inducing peripheral CFTR stabilization and apoptosis","volume":"215","author":"Taniguchi","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150433_bib14","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1172\/JCI118253","article-title":"A mouse model for the delta F508 allele of cystic fibrosis","volume":"96","author":"Zeiher","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2024.150433_bib15","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.kint.2018.02.025","article-title":"A mutation in transcription factor MAFB causes focal segmental glomerulosclerosis with duane retraction syndrome","volume":"94","author":"Sato","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2024.150433_bib16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm.3201","article-title":"A functional CFTR assay using primary cystic fibrosis intestinal organoids","volume":"19","author":"Dekkers","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.bbrc.2024.150433_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100019","article-title":"Protocol for application, standardization and validation of the forskolin-induced swelling assay in cystic fibrosis human colon organoids","volume":"1","author":"Vonk","year":"2020","journal-title":"STAR Protoc"},{"key":"10.1016\/j.bbrc.2024.150433_bib18","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/nprot.2013.153","article-title":"In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture","volume":"8","author":"Miyoshi","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbrc.2024.150433_bib19","doi-asserted-by":"crossref","first-page":"L71","DOI":"10.1152\/ajplung.00034.2019","article-title":"Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTR","volume":"317","author":"Bose","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.bbrc.2024.150433_bib20","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.37963","article-title":"SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion","volume":"7","author":"Ahmadi","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.bbrc.2024.150433_bib21","doi-asserted-by":"crossref","first-page":"15370","DOI":"10.1073\/pnas.0706974104","article-title":"Processing and function of CFTR-DeltaF508 are species-dependent","volume":"104","author":"Ostedgaard","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbrc.2024.150433_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/rcmb.2006-0184TR","article-title":"Cystic fibrosis mouse models","volume":"36","author":"Guilbault","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"Suppl 2","key":"10.1016\/j.bbrc.2024.150433_bib23","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1016\/S1569-1993(11)60020-9","article-title":"Mouse models of cystic fibrosis: phenotypic analysis and research applications","volume":"10","author":"Wilke","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.bbrc.2024.150433_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914539","article-title":"CFTR function restoration upon elexacaftor\/tezacaftor\/ivacaftor treatment in patient-derived intestinal organoids with rare","volume":"24","author":"Lefferts","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.150433_bib25","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbrc.2024.150433_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48105-4","article-title":"A BAC transgene expressing human CFTR under control of its regulatory elements rescues cftr knockout mice","volume":"9","author":"Gawenis","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150433_bib27","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1016\/j.cub.2008.11.040","article-title":"CARP2 deficiency does not alter induction of NF-kappaB by TNFalpha","volume":"19","author":"Ahmed","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbrc.2024.150433_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ph13040075","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) ubiquitylation as a novel pharmaceutical target for cystic fibrosis","volume":"13","author":"Fukuda","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbrc.2024.150433_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcf.2018.05.004","article-title":"CFTR modulator theratyping: current status, gaps and future directions","volume":"18","author":"Clancy","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.bbrc.2024.150433_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajpath.2020.10.017","article-title":"Animal and cell culture models for cystic fibrosis: which model is right for your application?","volume":"191","author":"McCarron","year":"2021","journal-title":"Am. J. Pathol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24009690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24009690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T13:52:06Z","timestamp":1733320326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24009690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":30,"alternative-id":["S0006291X24009690"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150433","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced CFTR modulator efficacy in \u0394F508 CFTR mouse organoids by ablation of RFFL ubiquitin ligase","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150433"}}